PSMA-targeted radioligand therapy in advanced prostate cancer: a narrative review of ^177Lu-PSMA, emerging ^225Ac-PSMA strategies, and therapeutic sequencing.

Gierulska N, Jankowska N, Kwiatkowska A, Kuchno P, Łysak K, Szklener K, Kośmider K, Skórzewska M

Open source

DOI
10.3389/or.2026.1834484
Published
2026
Container
Oncology reviews
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/or.2026.1834484,
  title = {PSMA-targeted radioligand therapy in advanced prostate cancer: a narrative review of \textasciicircum{}177Lu-PSMA, emerging \textasciicircum{}225Ac-PSMA strategies, and therapeutic sequencing.},
  author = {Gierulska N and Jankowska N and Kwiatkowska A and Kuchno P and Łysak K and Szklener K and Kośmider K and Skórzewska M},
  year = {2026},
  journal = {Oncology reviews},
  doi = {10.3389/or.2026.1834484},
  url = {https://doi.org/10.3389/or.2026.1834484}
}

RIS

TY  - JOUR
TI  - PSMA-targeted radioligand therapy in advanced prostate cancer: a narrative review of ^177Lu-PSMA, emerging ^225Ac-PSMA strategies, and therapeutic sequencing.
AU  - Gierulska N
AU  - Jankowska N
AU  - Kwiatkowska A
AU  - Kuchno P
AU  - Łysak K
AU  - Szklener K
AU  - Kośmider K
AU  - Skórzewska M
PY  - 2026
JO  - Oncology reviews
DO  - 10.3389/or.2026.1834484
UR  - https://doi.org/10.3389/or.2026.1834484
ER  - 

APA

N, G., N, J., A, K., P, K., K, Ł., K, S., K, K., & M, S. (2026). PSMA-targeted radioligand therapy in advanced prostate cancer: a narrative review of ^177Lu-PSMA, emerging ^225Ac-PSMA strategies, and therapeutic sequencing.. Oncology reviews. https://doi.org/10.3389/or.2026.1834484

Source records